Article
Modulation of Smooth Muscle Cell Phenotype for Translation of Tissue-Engineered Vascular Grafts.
Tissue engineering. Part B, Reviews - 1 Oct 2023
Pineda-Castillo Sergio A, Acar Handan, Detamore Michael S, Holzapfel Gerhard A, Lee Chung-Hao
Abstract excerpt
Translation of small-diameter tissue-engineered vascular grafts (TEVGs) for the treatment of coronary artery disease (CAD) remains an unfulfilled promise. This is largely due to the limited integration of TEVGs into the native vascular wall-a process hampered by the insufficient smooth muscle cell (SMC) infiltration and extracellular matrix deposition, and low vasoactivity. These processes can be promoted through...
Topics
Join the communities discussing this publication.
